On May 27, 2022 Invitae (NYSE: NVTA), a leading medical genetics company, reported that members of its management team will participate in the following investor conferences (Press release, Invitae, MAY 27, 2022, View Source [SID1234615172]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Invitae’s (NVTA) mission is to bring comprehensive genetic information into mainstream medical practice to improve the quality of healthcare for billions of people. www.invitae.com (PRNewsFoto/Invitae Corporation)

42nd Annual William Blair Growth Stock Conference – Formal presentation on Tuesday, June 7, 2022, at 8:40 a.m. Central Time in Chicago.
43rd Annual Goldman Sachs Global Healthcare Conference – Fireside chat on Wednesday, June 15, 2022, at 2:40 p.m. Pacific Time in Rancho Palos Verdes, CA.
A live audio webcast of each presentation may be accessed by visiting the investors section of the company website at ir.invitae.com. Replays of the webcasts will be available shortly after the conclusion of each presentation.